ZVRA
Zevra Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Zevra Therapeutics (ZVRA) Stock: Buy, Sell, or Hold?
$11.28
-0.57 (-4.85%)
▼
5d:
+7.08%
30d:
+10.22%
90d:
-0.4%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect ZVRA Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
43/100
Position
EXTENDED
30-Day Fair Range
$9.97 – $11.19
Position: EXTENDED
Forward P/E & Valuation
11.3x
FAIR
vs 10.3x historical avg
Wall Street Target
$25.25
+113.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.95 / $12.20
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ZVRA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ZVRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.17
Based on -1.1% avg growth
INTRINSIC VALUE TODAY
$6.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZVRA is currently trading at $11.28, which is considered extended relative to its 30-day fair value range of $9.97 to $11.19. The stock's valuation (Forward PE: 11.3) is in line with its historical norms (10.3). At these levels, the market is pricing in 3.0% annual earnings growth.
Technical Outlook: Technically, ZVRA is in a downtrend. Immediate support is located at $9.95, while resistance sits at $12.20. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: ZVRA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.25 (+113.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZVRA is in a downtrend. Immediate support is located at $9.95, while resistance sits at $12.20. Short-term momentum is weak, with the stock down 4.9% recently.
Market Sentiment: ZVRA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $25.25 (+113.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.97 -
$11.19
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$9.97 -
$11.19
Current vs Trading Range
EXTENDED
Support Level
$9.95
Resistance Level
$12.20
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding ZVRA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.9%)
- BULLISH: Trading 113.1% below Wall St target ($25.25)
- BULLISH: Expecting earnings turnaround to 3.0% growth with 44.9% revenue growth
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
11.29
Wall Street Target
$25.25
(+113.1%)
Revenue Growth (YoY)
44.9%
Earnings Growth (YoY)
-88.4%
Profit Margin
52.8%
Valuation Premium vs History
+3.0% premium
PE vs Historical
11.3 vs 10.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$12.21
(+3%)
2-Year Target
$12.57
(+6%)
3-Year Target
$12.95
(+9%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$11.82
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -6.3%)
$17.18
(+45%)
Base:
(SPY PE: 11.3, Growth: -6.3%)
$9.76
(-18%)
Bear:
(PE: 9.6, Growth: -6.3%)
$8.30
(-30%)
📈
Valuation based on Current Earnings
Trailing PE: 9.77 | Current EPS (TTM): $1.22
Bull Case
$11.28
(-5%)
Analyst growth -13.9%, PE expands to 10.8
Base Case
$10.26
(-13%)
Market implied -13.9%, PE stable at 9.8
Bear Case
$8.11
(-32%)
Severe decline -20.0%, PE contracts to 8.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ZVRA Analysis
Share this live ZVRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ZVRA)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $ZVRA, with traders anticipating a potential move on Friday.
Key Retail Themes:
Traders' confidence in future price movement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:52 PM ET
Data refreshes hourly during market hours. Next update: 2:52 PM
Data refreshes hourly during market hours. Next update: 2:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZVRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Advanced ZVRA Option Strategies
Professional options setups generated by AI based on today's ZVRA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ZVRA Research Pages
